<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04521673</url>
  </required_header>
  <id_info>
    <org_study_id>XH-20-014</org_study_id>
    <nct_id>NCT04521673</nct_id>
  </id_info>
  <brief_title>Pathogen Detection in Infectious Uveitis</brief_title>
  <official_title>Pathogen Detection in Infectious Uveitis in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infectious uveitis is a very important blinding disease. Some people who have been diagnosed&#xD;
      with idiopathic uveitis may also have the activity of pathogens in the eye. However, due to&#xD;
      the limitation of the amount of ocular samples, it is difficult to make a rapid and effective&#xD;
      diagnosis of infection.Current study is to explore the infective cause of uveitis in China by&#xD;
      using a broad diagnostic approach of detection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infectious uveitis is a very important blinding disease. Some people who have been diagnosed&#xD;
      with idiopathic uveitis may also have the activity of pathogens in the eye. However, due to&#xD;
      the limitation of the amount of ocular samples, it is difficult to make a rapid and effective&#xD;
      diagnosis of infection.&#xD;
&#xD;
      The study is to explore the infective cause of uveitis in China by using a broad diagnostic&#xD;
      approach of detection, including multiple molecular bio-techniques. We also plan to explore&#xD;
      the distribution of pathogens in infectious uveitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence and distribution of intraocular infections in the study group</measure>
    <time_frame>Oct 2020 to Sep 2022</time_frame>
    <description>Prevalence and distribution of intraocular infections in the study group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The sensitivity and specificity of multiple molecular diagnostic methods for detection of bacteria or virus fungi in the study group</measure>
    <time_frame>Oct 2020 to Sep 2022</time_frame>
    <description>The sensitivity and specificity of multiple molecular diagnostic methods for detection of bacteria or virus fungi in the study group</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infectious Panuveitis</condition>
  <condition>Infectious Iridocyclitis</condition>
  <arm_group>
    <arm_group_label>infectious uveitis</arm_group_label>
    <description>Patients suffering from suspected infectious uveitis, who have vitrectomy performed for diagnostic purpose or anterior chamber tap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients suffering from either cataract surgery or vitrectomy who has been ruled out for infectious ocular diseases</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Aqueous Humor and vitreous&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient at a referal hospital eye clinic with clinically suspected infectious uveitis, who&#xD;
        undergo AC tap or diagnostic vitrectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient at a referal hospital eye clinic with clinically suspected infectious uveitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not eligible for the Inclusion Criteria&#xD;
&#xD;
          -  Confirmed auto-immune uveitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ping Fei, MD，PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ping Fei, MD,PhD</last_name>
    <phone>86-13636342098</phone>
    <email>shirleypingfei@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xinhua Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ping Fei</last_name>
      <phone>86-13636342098</phone>
    </contact>
    <investigator>
      <last_name>Ping Fei, MD，PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>August 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2020</study_first_posted>
  <last_update_submitted>August 20, 2020</last_update_submitted>
  <last_update_submitted_qc>August 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Ping Fei</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>infectious uveitis</keyword>
  <keyword>pathogen</keyword>
  <keyword>PCR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Panuveitis</mesh_term>
    <mesh_term>Iridocyclitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>2 years after the study</ipd_time_frame>
    <ipd_access_criteria>if required propriately</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

